# CAMP4 THERAPEUTICS CORPORATION (CAMP)

> Source: Nexqual · https://nexqual.com/CAMP · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, CAMP4 THERAPEUTICS CORPORATION (CAMP), nexqual.com/CAMP" · informational, not investment advice.

**Price:** USD 3.45 (+0.58% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 3.43 · day 3.43–3.52 · 52w 2.86–7.75 · market cap $216M · NGM

## Key facts
- Analysts: Buy (mean 1.67 on a 1–5 scale) (9 analysts), mean target USD 10.25 (range 6–15).
- Total return with dividends: 1Y +10.9% vs S&P 500 +18.1%; 5Y -67.8% vs S&P 500 +85.1%.

## Analysts
Consensus Buy (mean 1.67 on a 1–5 scale), 9 analysts; mean target USD 10.25 (low 6, high 15).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-15 | Needham | Initiated | Buy | $8 |
| 2026-10-05 | Oppenheimer | Initiated | Outperform | $15 |
| 2026-09-29 | Chardan Capital | Target lowered | Buy | $6.5 → $6 |
| 2026-08-14 | Piper Sandler | Target raised | Overweight | $12 → $15 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2024-10-07) |
|---|---|---|
| Total return | +10.9% | -67.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +11.0% | -42.9% |
| Volatility (annualized) | 104.5% | 132.2% |
| Max drawdown | -57.8% (Dec 2025→Jul 2026) | -87.5% (Oct 2024→Jun 2025) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/CAMP · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt